Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-25-016898
Filing Date
2025-05-14
Accepted
2025-05-14 17:01:20
Documents
56
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q acrx20250331_10q.htm   iXBRL 10-Q 1044803
2 EXHIBIT 31.1 ex_814445.htm EX-31.1 7967
3 EXHIBIT 31.2 ex_814446.htm EX-31.2 7973
4 EXHIBIT 32.1 ex_814447.htm EX-32.1 5906
  Complete submission text file 0001437749-25-016898.txt   4657530

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA tlph-20250331.xsd EX-101.SCH 44763
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tlph-20250331_def.xml EX-101.DEF 289600
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlph-20250331_lab.xml EX-101.LAB 267198
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlph-20250331_pre.xml EX-101.PRE 310970
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tlph-20250331_cal.xml EX-101.CAL 25034
59 EXTRACTED XBRL INSTANCE DOCUMENT acrx20250331_10q_htm.xml XML 607311
Mailing Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404
Business Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404 650-216-3500
TALPHERA, INC. (Filer) CIK: 0001427925 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35068 | Film No.: 25946884
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)